Published in J Proteome Res on February 01, 2007
Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc Natl Acad Sci U S A (2009) 3.01
Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics. PLoS Pathog (2010) 2.48
Translational biomarker discovery in clinical metabolomics: an introductory tutorial. Metabolomics (2012) 2.18
Metabolic phenotyping in clinical and surgical environments. Nature (2012) 2.09
Metabolomics: Applications and Promise in Mycobacterial Disease. Ann Am Thorac Soc (2015) 1.96
LC-MS-based metabolomics in drug metabolism. Drug Metab Rev (2007) 1.79
Analysis of metabolomic PCA data using tree diagrams. Anal Biochem (2009) 1.57
1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death. Mol Syst Biol (2008) 1.51
Dengue virus infection perturbs lipid homeostasis in infected mosquito cells. PLoS Pathog (2012) 1.45
Metabolomic profiling reveals mitochondrial-derived lipid biomarkers that drive obesity-associated inflammation. PLoS One (2012) 1.27
Global urinary metabolic profiling procedures using gas chromatography-mass spectrometry. Nat Protoc (2011) 1.27
NMR-based stable isotope resolved metabolomics in systems biochemistry. J Biomol NMR (2011) 1.24
Metabolomics study of stepwise hepatocarcinogenesis from the model rats to patients: potential biomarkers effective for small hepatocellular carcinoma diagnosis. Mol Cell Proteomics (2011) 1.24
Quantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individuals. J Proteome Res (2012) 1.21
Metabolomics to unveil and understand phenotypic diversity between pathogen populations. PLoS Negl Trop Dis (2010) 1.21
RasGrf1 deficiency delays aging in mice. Aging (Albany NY) (2011) 1.16
Quantitative 1H NMR metabolomics reveals extensive metabolic reprogramming of primary and secondary metabolism in elicitor-treated opium poppy cell cultures. BMC Plant Biol (2008) 1.14
The role of mass spectrometry-based metabolomics in medical countermeasures against radiation. Mass Spectrom Rev (2010) 1.13
Multidimensional approaches to NMR-based metabolomics. Anal Chem (2013) 1.12
Diagnostic properties of metabolic perturbations in rheumatoid arthritis. Arthritis Res Ther (2011) 1.09
Individual variation in macronutrient regulation measured by proton magnetic resonance spectroscopy of human plasma. Am J Physiol Regul Integr Comp Physiol (2009) 1.08
Identification of serum biomarkers of hepatocarcinoma through liquid chromatography/mass spectrometry-based metabonomic method. Anal Bioanal Chem (2011) 1.07
Urinary metabolomic signature of esophageal cancer and Barrett's esophagus. World J Surg Oncol (2012) 1.04
Metabonomic profiles delineate the effect of traditional Chinese medicine sini decoction on myocardial infarction in rats. PLoS One (2012) 1.03
Nutritional lipidomics: molecular metabolism, analytics, and diagnostics. Mol Nutr Food Res (2013) 1.03
A global metabolic shift is linked to Salmonella multicellular development. PLoS One (2010) 1.03
Alterations in the Vaginal Microbiome by Maternal Stress Are Associated With Metabolic Reprogramming of the Offspring Gut and Brain. Endocrinology (2015) 1.02
Experimental bariatric surgery in rats generates a cytotoxic chemical environment in the gut contents. Front Microbiol (2011) 1.00
Statistical methods for the analysis of high-throughput metabolomics data. Comput Struct Biotechnol J (2013) 1.00
Ovarian cancer detection from metabolomic liquid chromatography/mass spectrometry data by support vector machines. BMC Bioinformatics (2009) 0.98
Piecewise multivariate modelling of sequential metabolic profiling data. BMC Bioinformatics (2008) 0.98
Interdependence of signal processing and analysis of urine 1H NMR spectra for metabolic profiling. Anal Chem (2009) 0.97
Gallic acid ameliorated impaired glucose and lipid homeostasis in high fat diet-induced NAFLD mice. PLoS One (2014) 0.97
Xenobiotic metabolism: a view through the metabolometer. Chem Res Toxicol (2010) 0.96
Random forest in clinical metabolomics for phenotypic discrimination and biomarker selection. Evid Based Complement Alternat Med (2013) 0.95
Bioinformatics: the next frontier of metabolomics. Anal Chem (2014) 0.95
Clinical metabolomics paves the way towards future healthcare strategies. Br J Clin Pharmacol (2013) 0.95
Integrated cytokine and metabolic analysis of pathological responses to parasite exposure in rodents. J Proteome Res (2010) 0.95
¹H NMR-based serum metabolic profiling in compensated and decompensated cirrhosis. World J Gastroenterol (2012) 0.94
Quantitative 1H nuclear magnetic resonance metabolite profiling as a functional genomics platform to investigate alkaloid biosynthesis in opium poppy. Plant Physiol (2008) 0.93
Metabolomic profiling in blood from umbilical cords of low birth weight newborns. J Transl Med (2012) 0.93
Obesity Increases Mortality and Modulates the Lung Metabolome during Pandemic H1N1 Influenza Virus Infection in Mice. J Immunol (2015) 0.93
¹H NMR-based metabolic profiling of human rectal cancer tissue. Mol Cancer (2013) 0.92
Metabolomic approach to evaluating adriamycin pharmacodynamics and resistance in breast cancer cells. Metabolomics (2013) 0.92
Development of metabolic and inflammatory mediator biomarker phenotyping for early diagnosis and triage of pediatric sepsis. Crit Care (2015) 0.92
Can we trust untargeted metabolomics? Results of the metabo-ring initiative, a large-scale, multi-instrument inter-laboratory study. Metabolomics (2014) 0.91
A (1)H NMR-Based Metabonomic Investigation of Time-Related Metabolic Trajectories of the Plasma, Urine and Liver Extracts of Hyperlipidemic Hamsters. PLoS One (2013) 0.91
Ectopic fat storage in the pancreas using 1H-MRS: importance of diabetic status and modulation with bariatric surgery-induced weight loss. Int J Obes (Lond) (2014) 0.90
Integration of metabolic and inflammatory mediator profiles as a potential prognostic approach for septic shock in the intensive care unit. Crit Care (2015) 0.90
Serum metabolic profiling of human gastric cancer based on gas chromatography/mass spectrometry. Braz J Med Biol Res (2011) 0.89
Fatty acid composition of adipose tissue triglycerides after weight loss and weight maintenance: the DIOGENES study. Physiol Res (2012) 0.89
Application of (1)h NMR spectroscopy-based metabolomics to sera of tuberculosis patients. J Proteome Res (2013) 0.89
Panorganismal metabolic response modeling of an experimental Echinostoma caproni infection in the mouse. J Proteome Res (2009) 0.89
Constrained randomization and multivariate effect projections improve information extraction and biomarker pattern discovery in metabolomics studies involving dependent samples. Metabolomics (2015) 0.88
Individual differences in metabolomics: individualised responses and between-metabolite relationships. Metabolomics (2012) 0.88
Metabolomics-driven nutraceutical evaluation of diverse green tea cultivars. PLoS One (2011) 0.88
Between Metabolite Relationships: an essential aspect of metabolic change. Metabolomics (2011) 0.87
Alterations of red blood cell metabolome in overhydrated hereditary stomatocytosis. Haematologica (2011) 0.87
Metabolomic analysis of human disease and its application to the eye. J Ocul Biol Dis Infor (2009) 0.87
Large-scale human metabolic phenotyping and molecular epidemiological studies via 1H NMR spectroscopy of urine: investigation of borate preservation. Anal Chem (2009) 0.87
Towards polypharmacokinetics: pharmacokinetics of multicomponent drugs and herbal medicines using a metabolomics approach. Evid Based Complement Alternat Med (2013) 0.87
Caloric restriction reveals a metabolomic and lipidomic signature in liver of male mice. Aging Cell (2014) 0.86
Human liver tissue metabolic profiling research on hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol (2013) 0.86
Potential biomarkers in mouse myocardium of doxorubicin-induced cardiomyopathy: a metabonomic method and its application. PLoS One (2011) 0.85
Multi-platform metabolomic analyses of ergosterol-induced dynamic changes in Nicotiana tabacum cells. PLoS One (2014) 0.85
Metabolic changes reveal the development of schistosomiasis in mice. PLoS Negl Trop Dis (2010) 0.85
A sulfur amino acid-free meal increases plasma lipids in humans. J Nutr (2011) 0.85
Exhaled volatile organic compounds as lung cancer biomarkers during one-lung ventilation. Sci Rep (2014) 0.85
Association of urinary metabolites with radiographic progression of knee osteoarthritis in overweight and obese adults: an exploratory study. Osteoarthritis Cartilage (2016) 0.84
Chronic myeloid leukemia patients sensitive and resistant to imatinib treatment show different metabolic responses. PLoS One (2010) 0.84
Changes in metabolic phenotypes of Plasmodium falciparum in vitro cultures during gametocyte development. Malar J (2014) 0.83
Altered metabolic signature in pre-diabetic NOD mice. PLoS One (2012) 0.83
Calcium-deficiency assessment and biomarker identification by an integrated urinary metabonomics analysis. BMC Med (2013) 0.83
Gram-negative and Gram-positive bacterial infections give rise to a different metabolic response in a mouse model. J Proteome Res (2012) 0.82
A guide to the identification of metabolites in NMR-based metabonomics/metabolomics experiments. Comput Struct Biotechnol J (2016) 0.82
Perturbations in the lipid profile of individuals with newly diagnosed type 1 diabetes mellitus: lipidomics analysis of a Diabetes Antibody Standardization Program sample subset. Clin Biochem (2010) 0.82
Blood volatile compounds as biomarkers for colorectal cancer. Cancer Biol Ther (2013) 0.82
Identification of serum biomarkers for lung cancer using magnetic bead-based SELDI-TOF-MS. Acta Pharmacol Sin (2011) 0.82
Metabonomics-based omics study and atherosclerosis. J Clin Bioinforma (2011) 0.82
Validated and predictive processing of gas chromatography-mass spectrometry based metabolomics data for large scale screening studies, diagnostics and metabolite pattern verification. Metabolites (2012) 0.81
Metabolomics Study of Resina Draconis on Myocardial Ischemia Rats Using Ultraperformance Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry Combined with Pattern Recognition Methods and Metabolic Pathway Analysis. Evid Based Complement Alternat Med (2013) 0.81
Non-invasive fecal metabonomic detection of colorectal cancer. Cancer Biol Ther (2014) 0.81
Metabolic characterization of Leishmania major infection in activated and nonactivated macrophages. J Proteome Res (2012) 0.81
Combined effects of a high-fat diet and chronic valproic acid treatment on hepatic steatosis and hepatotoxicity in rats. Acta Pharmacol Sin (2014) 0.81
Direct Analysis in Real Time Mass Spectrometry (DART-MS) Analysis of Skin Metabolome Changes in the Ultraviolet B-Induced Mice. Biomol Ther (Seoul) (2013) 0.81
Metabolic Profiling of Systemic Lupus Erythematosus and Comparison with Primary Sjögren's Syndrome and Systemic Sclerosis. PLoS One (2016) 0.81
Development of a Direct Headspace Collection Method from Arabidopsis Seedlings Using HS-SPME-GC-TOF-MS Analysis. Metabolites (2013) 0.81
A review of the "Omics" approach to biomarkers of oxidative stress in Oryza sativa. Int J Mol Sci (2013) 0.81
Metabolic profiling of vitamin C deficiency in Gulo-/- mice using proton NMR spectroscopy. J Biomol NMR (2011) 0.80
A data preprocessing strategy for metabolomics to reduce the mask effect in data analysis. Front Mol Biosci (2015) 0.80
Simultaneous analysis of plasma and CSF by NMR and hierarchical models fusion. Anal Bioanal Chem (2012) 0.80
Effect of tea theaflavins and catechins on microvascular function. Nutrients (2014) 0.80
1H Nuclear Magnetic Resonance (NMR) Metabolomic Study of Chronic Organophosphate Exposure in Rats. Metabolites (2012) 0.79
Malignancy-associated metabolic profiling of human glioma cell lines using 1H NMR spectroscopy. Mol Cancer (2014) 0.79
Emerging applications of metabolomics in studying chemopreventive phytochemicals. AAPS J (2013) 0.79
Multivariate metabotyping of plasma predicts survival in patients with decompensated cirrhosis. J Hepatol (2016) 0.79
Impacts of plant-based foods in ancestral hominin diets on the metabolism and function of gut microbiota in vitro. MBio (2014) 0.79
Unraveling the concentration-dependent metabolic response of Pseudomonas sp. HF-1 to nicotine stress by ¹H NMR-based metabolomics. Ecotoxicology (2012) 0.79
Metabolomic analysis of pancreatic β-cell insulin release in response to glucose. Islets (2012) 0.78
A Metabonomics Profiling Study on Phlegm Syndrome and Blood-Stasis Syndrome in Coronary Heart Disease Patients Using Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry. Evid Based Complement Alternat Med (2014) 0.78
Host-gut microbiota metabolic interactions. Science (2012) 7.73
Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science (2013) 6.98
Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci U S A (2008) 6.42
Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov (2002) 5.96
Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc (2007) 5.92
Gut microorganisms, mammalian metabolism and personalized health care. Nat Rev Microbiol (2005) 5.35
Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci U S A (2006) 5.19
Statistical total correlation spectroscopy: an exploratory approach for latent biomarker identification from metabolic 1H NMR data sets. Anal Chem (2005) 4.14
Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med (2002) 3.91
A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model. Mol Syst Biol (2007) 3.68
Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. Gut (2011) 3.42
Summary recommendations for standardization and reporting of metabolic analyses. Nat Biotechnol (2005) 2.90
Multiple parasite infections and their relationship to self-reported morbidity in a community of rural Côte d'Ivoire. Int J Epidemiol (2004) 2.84
Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc Natl Acad Sci U S A (2010) 2.52
Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model. Mol Syst Biol (2008) 2.43
Global metabolic profiling procedures for urine using UPLC-MS. Nat Protoc (2010) 2.18
Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes. Mol Syst Biol (2008) 2.17
NMR-based metabonomic approaches for evaluating physiological influences on biofluid composition. NMR Biomed (2005) 2.15
Metabonomic investigations in mice infected with Schistosoma mansoni: an approach for biomarker identification. Proc Natl Acad Sci U S A (2004) 2.11
Metabolic phenotyping in clinical and surgical environments. Nature (2012) 2.09
Colonization-induced host-gut microbial metabolic interaction. MBio (2011) 2.04
The challenges of modeling mammalian biocomplexity. Nat Biotechnol (2004) 2.03
Optimized preprocessing of ultra-performance liquid chromatography/mass spectrometry urinary metabolic profiles for improved information recovery. Anal Chem (2011) 2.02
Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res (2007) 1.99
Susceptibility of human metabolic phenotypes to dietary modulation. J Proteome Res (2006) 1.96
Chemometrics in metabolomics--a review in human disease diagnosis. Anal Chim Acta (2009) 1.96
Metabonomics in pharmaceutical R&D. FEBS J (2007) 1.93
Using chemometrics for navigating in the large data sets of genomics, proteomics, and metabonomics (gpm). Anal Bioanal Chem (2004) 1.88
The human gut microbiome: implications for future health care. Curr Gastroenterol Rep (2008) 1.84
A genome-wide metabolic QTL analysis in Europeans implicates two loci shaped by recent positive selection. PLoS Genet (2011) 1.83
Scaling and normalization effects in NMR spectroscopic metabonomic data sets. Anal Chem (2006) 1.81
Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Biomarkers (2004) 1.79
Global metabolic responses of NMRI mice to an experimental Plasmodium berghei infection. J Proteome Res (2008) 1.78
NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology. Chem Res Toxicol (2008) 1.77
Assessment of analytical reproducibility of 1H NMR spectroscopy based metabonomics for large-scale epidemiological research: the INTERMAP Study. Anal Chem (2006) 1.76
High-resolution magic-angle-spinning NMR spectroscopy for metabolic profiling of intact tissues. Nat Protoc (2010) 1.76
Metabonomic and microbiological analysis of the dynamic effect of vancomycin-induced gut microbiota modification in the mouse. J Proteome Res (2008) 1.67
Application of chemometrics to 1H NMR spectroscopic data to investigate a relationship between human serum metabolic profiles and hypertension. Analyst (2003) 1.65
Statistical heterospectroscopy, an approach to the integrated analysis of NMR and UPLC-MS data sets: application in metabonomic toxicology studies. Anal Chem (2006) 1.61
Human metabolic profiles are stably controlled by genetic and environmental variation. Mol Syst Biol (2011) 1.60
Recursive segment-wise peak alignment of biological (1)h NMR spectra for improved metabolic biomarker recovery. Anal Chem (2009) 1.59
Rapid diagnosis and staging of colorectal cancer via high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy of intact tissue biopsies. Ann Surg (2014) 1.58
Top-down systems biology modeling of host metabotype-microbiome associations in obese rodents. J Proteome Res (2009) 1.57
Metabonomics techniques and applications to pharmaceutical research & development. Pharm Res (2006) 1.55
Mistargeting of peroxisomal EHHADH and inherited renal Fanconi's syndrome. N Engl J Med (2014) 1.53
Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls. J Proteome Res (2010) 1.50
So what's the deal with metabonomics? Anal Chem (2003) 1.43
A metabonomic strategy for the detection of the metabolic effects of chamomile (Matricaria recutita L.) ingestion. J Agric Food Chem (2005) 1.42
Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Environ Microbiol (2008) 1.42
The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements. Pharmacogenomics (2005) 1.41
Urinary metabolic phenotyping the slc26a6 (chloride-oxalate exchanger) null mouse model. J Proteome Res (2012) 1.41
Metabolic changes in schizophrenia and human brain evolution. Genome Biol (2008) 1.39
High-throughput 1H NMR-based metabolic analysis of human serum and urine for large-scale epidemiological studies: validation study. Int J Epidemiol (2008) 1.39
Classification of G-protein coupled receptors by alignment-independent extraction of principal chemical properties of primary amino acid sequences. Protein Sci (2002) 1.33
Opening up the "Black Box": metabolic phenotyping and metabolome-wide association studies in epidemiology. J Clin Epidemiol (2010) 1.31
Species variation in the fecal metabolome gives insight into differential gastrointestinal function. J Proteome Res (2007) 1.30
Impact of analytical bias in metabonomic studies of human blood serum and plasma. Anal Chem (2006) 1.29
Geometric trajectory analysis of metabolic responses to toxicity can define treatment specific profiles. Chem Res Toxicol (2004) 1.26
Statistically integrated metabonomic-proteomic studies on a human prostate cancer xenograft model in mice. J Proteome Res (2006) 1.25
Global metabolic responses of mice to Trypanosoma brucei brucei infection. Proc Natl Acad Sci U S A (2008) 1.24
Application of biofluid 1H nuclear magnetic resonance-based metabonomic techniques for the analysis of the biochemical effects of dietary isoflavones on human plasma profile. Anal Biochem (2003) 1.24
Gut microbiome modulates the toxicity of hydrazine: a metabonomic study. Mol Biosyst (2009) 1.24
Phylometabonomic patterns of adaptation to high fat diet feeding in inbred mice. PLoS One (2008) 1.23
Metabonomic investigations of aging and caloric restriction in a life-long dog study. J Proteome Res (2007) 1.21
Panorganismal gut microbiome-host metabolic crosstalk. J Proteome Res (2009) 1.18
Metabonomic deconvolution of embedded toxicity: application to thioacetamide hepato- and nephrotoxicity. Chem Res Toxicol (2005) 1.17
Metabolic profiling and the metabolome-wide association study: significance level for biomarker identification. J Proteome Res (2010) 1.16
Proteochemometrics modeling of the interaction of amine G-protein coupled receptors with a diverse set of ligands. Mol Pharmacol (2002) 1.16
Transgenomic metabolic interactions in a mouse disease model: interactions of Trichinella spiralis infection with dietary Lactobacillus paracasei supplementation. J Proteome Res (2006) 1.16
Metabolome-wide association study identifies multiple biomarkers that discriminate north and south Chinese populations at differing risks of cardiovascular disease: INTERMAP study. J Proteome Res (2010) 1.15
Analytical reproducibility in (1)H NMR-based metabonomic urinalysis. Chem Res Toxicol (2002) 1.15
Variation in antibiotic-induced microbial recolonization impacts on the host metabolic phenotypes of rats. J Proteome Res (2011) 1.13
Global metabolic profiling of animal and human tissues via UPLC-MS. Nat Protoc (2012) 1.13
Precision high-throughput proton NMR spectroscopy of human urine, serum, and plasma for large-scale metabolic phenotyping. Anal Chem (2014) 1.12
Spectral editing and pattern recognition methods applied to high-resolution magic-angle spinning 1H nuclear magnetic resonance spectroscopy of liver tissues. Anal Biochem (2003) 1.12
Diet composition and activity level of at risk and metabolically healthy obese American adults. Obesity (Silver Spring) (2013) 1.12
HILIC-UPLC-MS for exploratory urinary metabolic profiling in toxicological studies. Anal Chem (2010) 1.12
Metabolic assessment of human liver transplants from biopsy samples at the donor and recipient stages using high-resolution magic angle spinning 1H NMR spectroscopy. Anal Chem (2005) 1.11
Metabotyping of long-lived mice using 1H NMR spectroscopy. J Proteome Res (2012) 1.11
Aberrant adiposity and ectopic lipid deposition characterize the adult phenotype of the preterm infant. Pediatr Res (2011) 1.11
Stability and robustness of human metabolic phenotypes in response to sequential food challenges. J Proteome Res (2011) 1.10
Top-down systems biology integration of conditional prebiotic modulated transgenomic interactions in a humanized microbiome mouse model. Mol Syst Biol (2008) 1.10
Optimization of human plasma 1H NMR spectroscopic data processing for high-throughput metabolic phenotyping studies and detection of insulin resistance related to type 2 diabetes. Anal Chem (2008) 1.10
Diagnostic properties of metabolic perturbations in rheumatoid arthritis. Arthritis Res Ther (2011) 1.09
Extraction, interpretation and validation of information for comparing samples in metabolic LC/MS data sets. Analyst (2005) 1.09
Metabolic surgery and cancer: protective effects of bariatric procedures. Cancer (2010) 1.09
Systems toxicology: integrated genomic, proteomic and metabonomic analysis of methapyrilene induced hepatotoxicity in the rat. J Proteome Res (2006) 1.08
1H HR-MAS NMR spectroscopy of tumor-induced local metabolic "field-effects" enables colorectal cancer staging and prognostication. J Proteome Res (2013) 1.08
NMR and pattern recognition studies on liver extracts and intact livers from rats treated with alpha-naphthylisothiocyanate. Biochem Pharmacol (2002) 1.08
Metabolic characterization of the R6/2 transgenic mouse model of Huntington's disease by high-resolution MAS 1H NMR spectroscopy. J Proteome Res (2006) 1.08
Metabonomics and its role in drug development and disease diagnosis. Expert Rev Mol Diagn (2004) 1.07
Determination of drug-plasma protein binding kinetics and equilibria by chromatographic profiling: exemplification of the method using L-tryptophan and albumin. Anal Chem (2002) 1.07
Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach. J Proteome Res (2007) 1.07
Experimental and analytical variation in human urine in 1H NMR spectroscopy-based metabolic phenotyping studies. Anal Chem (2007) 1.06
Effects of probiotic Lactobacillus paracasei treatment on the host gut tissue metabolic profiles probed via magic-angle-spinning NMR spectroscopy. J Proteome Res (2007) 1.05
Comparative metabonomics of differential hydrazine toxicity in the rat and mouse. Toxicol Appl Pharmacol (2005) 1.05
Metabonomics: systems biology in pharmaceutical research and development. Curr Opin Mol Ther (2004) 1.05